as 05-20-2024 3:31pm EST
Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Founded: | 1984 | Country: | United States |
Employees: | N/A | City: | FOOTHILL RANCH |
Market Cap: | 5.6M | IPO Year: | 1992 |
Target Price: | $14.80 | AVG Volume (30 days): | 5.5M |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -20.34 | EPS Growth: | N/A |
52 Week Low/High: | $0.13 - $17.00 | Next Earning Date: | 05-13-2024 |
Revenue: | $48,828,000 | Revenue Growth: | 0.13% |
Revenue Growth (this year): | 6.85% | Revenue Growth (next year): | 7.77% |
BIOL Breaking Stock News: Dive into BIOL Ticker-Specific Updates for Smart Investing
Thomson Reuters StreetEvents
6 days ago
GuruFocus.com
7 days ago
Associated Press Finance
7 days ago
ACCESSWIRE
7 days ago
ACCESSWIRE
14 days ago
Insider Monkey
2 months ago
Thomson Reuters StreetEvents
2 months ago
Associated Press Finance
2 months ago